HRT Financial’s HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HHLA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-54,526
Closed -$1K 3360
2023
Q4
$1K Hold
54,526
﹤0.01% 2226
2023
Q3
$1K Sell
54,526
-100
-0.2% -$3 ﹤0.01% 2301
2023
Q2
$1K Buy
54,626
+100
+0.2% +$5 ﹤0.01% 2339
2023
Q1
$3K Hold
54,526
﹤0.01% 2333
2022
Q4
$2K Buy
+54,526
New +$3.5K ﹤0.01% 2346

HRT Financial's HHLA.WS Position: Q1 2024 in Review

HRT Financial sold out of HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HHLA.WS) in Q1 2024, closing a stake of 54,526 shares — an estimated $1K sold.

HRT Financial first reported a position in HHLA.WS in Q4 2022 and held it in 5 quarters. The position peaked at $3K in Q1 2023. 0 funds tracked by Wall St. Rank hold HHLA.WS as of Q1 2024.

  • HRT Financial reported no remaining HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 54,526 HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2024, an estimated $1K.
  • HRT Financial first reported a position in HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2022 and held it in 5 quarters.
  • HRT Financial's HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $3K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.